Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: Genetic background of male centenarians is protective against coronary heart disease

Journal of Medical Genetics

Volumn 41, Issue 10, 2004, Pages 790-794

  Lio, D ^a   Candore, G ^a   Crivello, A ^a   Scola, L ^a   Colonna Romano, G ^a   Cavallone, L ^a,c   Hoffmann, E ^a   Caruso, M ^a   Licastro, F ^b   Caldarera, C M ^b   Branzi, A ^b   Franceschi, C ^b,c   Caruso, C ^a,d  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INRCA   (Italy)

^d Grup di Stud dell'Immunosenescenza   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 10;

ACUTE HEART INFARCTION; ADULT; AGED; AGING; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CENTENARIAN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; GROUPS BY AGE; HEREDITY; HUMAN; IMMUNE SYSTEM; INFECTION RESISTANCE; INFLAMMATION; ISCHEMIC HEART DISEASE; ITALY; LONGEVITY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALLELES; BASE SEQUENCE; CARDIOVASCULAR DISEASES; HAPLOTYPES; HUMANS; INTERLEUKIN-10; ITALY; LONGEVITY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC;

EID: 3943106903     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2004.019885     Document Type: Article

References (53)

1. Perls T, Terry D. Understanding the determinants of exceptional longevity. Ann Intern Med 2003;139:445-9.
2. Terry DF, Wilcox M, McCormick MA, Lawler E, Perls TT. Cardiovascular advantages among the offspring of centenarians. J Gerontol A Biol Sci Med Sci 2003;58:M425-31.
3. Franceschi C, Donate M. Centenarians as a model far healthy aging. Biochem Soc Trans 2003;31:457-61.
4. Rass R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
5. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
6. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
7. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
8. Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin 2003;21:315-25.
9. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997;17:1859-67.
10. Nobel EG. Cardiovascular disease. N Engl J Med 2003;349:60-72.
11. Andreotti F, Porto I, Crea F, Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 2002;87:107-12.
12. Stephens JW, Humphries SE. The molecular genetics of cardiovascular disease: clinical implications. J Intern Med 2003;253:120-7.
13. Lio D, Caruso C. IL-10, genetic polymorphism and its relevance to age-related diseases. In: Marincola F, ed. Interleukin-10. Georgetown, TX: Landes Bioscience (in press).
14. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
15. Sato K, Nagayama H, Tadokoro K, Juji T, Takahashi TA. Extracellular signal-regulated kinase stress-activated protein kinase/c-jun N-terminal kinase and p38 Mapkare involved in IL-10 mediated selective repression of TNF-alpha induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. J Immunol 1999;162:3865-72.
16. Kube D, Rieth H, Eskdale J, Kremsner PG, Gallagher G. Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene. Genes Immun 2001;2:181-90.
17. Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-3.
18. Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C. A genetically determined high setting of TNF-α influences immunological parameters of HLA-B8, DR3 positive subjects: implications far autoimmunity. Human Immunol 2001;62:705-13.
19. Koss K, Fanning GC, Welsh KI, Jewell DP. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3′ mismatches in forward and reverse primers. Genes Immun 2000;1:321-4.
20. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
21. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Donate M, Cavallone L, Franceschi C, Caruso C. Gender-specific association between - 1082 IL-10 promoter polymorphism and longevity. Genes Immun 2002;3:30-3.
22. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Donate M, Cavallone L, Marchegiani F, Olivieri F, Franceschi C, Caruso C. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet 2003;40:296-9.
23. Reynard MP, Turner D, Novarrete CV. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interteron-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet 2000;27:241-9.
24. Ross OA, Curran MD, Meenagh A, Williams F, Darnett YA, Middleton D, Rea IM. Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev 2003;124:199-206.
25. Uboldi de Capei MU, Dametto E, Fasano ME, Rendine S, Curtoni ES. Genotyping for cytokine polymorphisms: allele frequencies in the Italian population. Eur J Immunogenet 2003;30:5-10.
26. Westendorp RG, van Dunne FM, Kirkwood TD, Heimerhorst FM, Huizinga TW. Optimizing human fertility and survival. Nat Med 2001;7:873.
27. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001;166:3915-22.
28. Crawley E, Kay R, Sillibourne J, Potel P, Hutchinsan I, Woo P. Polymorphic haplotypes of me interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:1101-8.
29. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998;95:9465-70.
30. Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to farm four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1999;1:151-5.
31. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL-10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997;46:120-8.
32. Donger C, Georges JL, Nicaud V, Morrison C, Evans A, Kee F, Arveiler D, Tiret L, Combien F. New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction. Eur J Clin Invest 2001;31:9-14.
33. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun 2000;1:231-3.
34. Suarez A, Castro P, Alonso R, Mozo L, Gutierrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with generic polymorphisms. Transplantation 2003;75:711-7.
35. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, Colonna-Romano G, Candore G, Franceschi C, Caruso C. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun 2003;4:234-8.
36. Scala L, Crivello A, Marino V, Gioia V, Serouto A, Candore G, Colonna-Romano G, Caruso C, Lio D. IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication far ageing and life span expectancy. Mech Ageing Dev 2003;124:569-72.
37. Lio D, Caruso C, Di Stefano R, Colonna Romano G, Ferraro D, Scola L, Crivello A, Licata A, Valenza LM, Candore G, Craxi A, Almasio PL. IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection. Hum Immunol 2003;64:674-80.
38. Tedgui A, Mallat Z. Interleukin-10: an anti-atherogenic cytokine. Pathol Biol (Paris) 2001;49:107-8.
39. Pinderski LJ, Fischbein MP, Subbonagounder G, Fishbein MC, Kubo N, Cheroutre H, Curriss LK, Berliner JA, Boisvert WA. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenatypes. Cire Res 2002;90:1064-71.
40. Vosse M, Paysant I, Soria J, Mirshahi SS, Vannier JP, Soria C. Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. Br J Haematol 1996;93:955-61.
41. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999;85:e17-24.
42. Raisanen-Sakalawski A, Ghysing-Jensen T, Russell ME. Leukocyte- suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am J Pathol 1998;153:1491-500.
43. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the anti-inflammatary cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001;104:746-9.
44. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM; CAPTURE Study Investigators. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003;107:2109-14.
45. Koch W, Kastrati A, Bottiger C, Mehilli J, van Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001;159:137-44.
46. Koch W, Tiroch K, von Beckerath N, Schomig A, Kastrati A. Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine 2003;24:161-71.
47. Girndt M, Ulrich C, Kaul H, Sester U, Sester M, Kohler H. Uremia-associated immune defect: the IL-10-CRP axis. Kidney Int Suppl 2003;84:S76-9.
48. Massaro M, Carluccio MA, De Caterina R. Direct vascular antiatherogenic effects of oleic acid: a clue to the cardioprotective effects of the Mediterranean diet. Cardiologia 1999;44:507-13.
49. Barzi F, Woodward M, Marfisi RM, Tavazzi L, Valagussa F, Marchioli R, GISSI-Prevenzione Investigators. Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr 2003;57:604-11.
50. Atzmon G, Schechter C, Greiner W, Davidson D, Rennert G, Barzilai N. Clinical phenotype of families with longevity. J Am Geriatr Soc 2004;52:274-7.
51. Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, Upton R, Cheng S, Shuldiner AR. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003;290:2030-40.
52. Nesse RM, Williams GC, Franceschi C. Evolution and healing. The new science of Darwinian medicine. London: Weidenfeld and Nicolson, 1995.
53. Mariani L, Turchefri G, Franceschi C. Chronic antigenic stress, immunosenescence and human survivorship over the 3 last centuries: heuristic value of a mathematical model. Mech Ageing Dev 2003;124:453-8.